The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non-U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.

Eli Lilly and Company

Johnson & Johnson

Merck & Co., Inc.

Guardant Health, Inc.

UnitedHealth Group Incorporated

argenx SE

Intuitive Surgical, Inc.

Cencora, Inc.

DexCom, Inc.

Agilent Technologies, Inc.

Healthcare

Consumer Defensive

Cash & Others

Goldman Sachs Future Health Care Equity ETF

GDOC Holdings & Sector Breakdown

GDOC Holdings & Sector Breakdown